Amgen
Company Overview
Keywords
Description
Amgen is a pioneering biotechnology company that blends biology and technology to combat challenging diseases and enhance people's quality of life. With a history of shaping the biotechnology industry, Amgen continues to lead the way in innovation by leveraging technology and human genetic data to explore new frontiers in healthcare. Through significant investments in research and development, Amgen has built a diverse pipeline of medications targeting cancer, heart disease, osteoporosis, inflammatory diseases, and rare conditions. Among the esteemed group of companies in the Dow Jones Industrial Average® and the Nasdaq-100 Index®, Amgen has been recognized for its commitment to innovation and employee satisfaction. In 2024, Amgen was honored as one of the 'World's Most Innovative Companies' by Fast Company and as one of 'America's Best Large Employers' by Forbes. For more insights into Amgen's work and initiatives, visit Amgen.com and engage with the company on various social media platforms such as X, LinkedIn, Instagram, TikTok, YouTube, and Threads. Stay informed by reviewing Amgen's Community Guidelines at https://wwwext.amgen.com/community-guidelines and refer to the Global Privacy Statement Directory at www.amgen.com/dp for information on privacy practices. A special advisory from Amgen cautions individuals against fraudulent recruitment offers falsely attributed to the company. These scams, often originating from fake websites or unsolicited emails, aim to deceive individuals into providing personal information or payment for non-existent job opportunities. Amgen emphasizes that it never solicits payment for job applications. To verify the authenticity of a job posting, please visit the official Amgen website. If you encounter suspicious recruitment activities, report them promptly at https://complaint.ic3.gov/. Thank you for your cooperation in maintaining a safe recruitment environment.
Funding History
| Date | Round | Amount | Lead Investors |
|---|---|---|---|
| Dec 12, 2022 | Post-IPO Debt | $28,500,000,000 | N/A |
Technology Stack
+983 more technologies
Key Employees
View AllFind Executive job changes at Amgen
Frequently Asked Questions
Employee Statistics
By Seniority
Similar Companies
10x Genomics
Business Services
Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.
Exelixis
Business Services
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/2XXw9w3 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
GRAIL
Business Services
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com. Community Guidelines: https://bit.ly/3xigb24